Fortress Biotech Corp (FBIO): Price-to-Revenue Coefficient

Corporate company logo of Fortress Biotech Inc (FBIO)

The foundation of growth for Fortress Biotech, Inc. (FBIO) is the integration of ESG principles into the management of oncology projects and synthesis safety controls. The current price-to-sales ratio confirms this trend, where 1.00 represents the current metric value. External conditions include the risk of resource dilution across competitive niches, although the holding company model provides diversification for a drug portfolio at various trial stages.

FBIO: Fortress Price-to-Revenue Ratio 07/04/2022 - 11/13/2026

Analytical breakdowns for Fortress (FBIO)

- stock value and consensus price forecast:
Stock Price fortressbiotech.com|FBIO - Price Target Chart
- stock exchange capitalization data:
Market Capitalization Fortress|FBIO - Real Price to Acquire Entire Company
- company book value details:
Accounting Value of a Share Fortress Biotech|FBIO - Company Book Value|Market-to-Book Ratio fortressbiotech.com|FBIO - Aggregate Company Assets
- business debt structure and liquidity details:
Debt to Equity Ratio Fortress Biotech, Inc.|FBIO - Long-Term Debt to Capital|Short-Term Debt to Equity Ratio Fortress Biotech Corp|FBIO - Company Debts|Debts to Book Value Fortress|FBIO - Company Long-Term Debt|Company Short-Term Debt Fortress Biotech|Immediate Liquidity fortressbiotech.com
- earnings and valuation multiples information:
FBIO - Net Profit|Projected Net Profit Fortress Biotech, Inc.|FBIO - Price to Earnings Ratio|Projected Price to Earnings Ratio Fortress Biotech Inc|FBIO - PEG Multiple|Company Value to Operating Income Before Depreciation Ratio Fortress|FBIO - Profit before payment of interest, taxes and amortization|Net earnings per one share for the last twelve months Fortress Biotech|FBIO - Earnings per share for the last twelve months|Year-over-year earnings per one share growth for the last 12 months fortressbiotech.com|FBIO - Net earnings per share growth this year|Projected earnings per share increase next year Fortress Biotech, Inc.
- total revenue and sales volume data:
FBIO - Company Revenue|Company Future Revenue fortressbiotech.com|FBIO - P/S Multiple|Market Cap to Future Revenue Ratio Fortress
Fundamental company analysis:FBIO - fortressbiotech.com
Manufactured products of Fortress Biotech, Inc.

The multiple is calculated by dividing the market capitalization by total sales, determining the cost of each unit of revenue. This indicator allows for the comparison of the current market valuation with historical data to identify whether the asset is overbought or undervalued. For Fortress Biotech, Inc. (FBIO), this calculation reflects the efficiency of molecule portfolio management and the complexities of licensing structuring. The price/sales trend helps investors assess the fair value of the business, considering the high barrier to entry.

Competitors of Fortress Biotech, Inc.

P/S Multiple novocure.com (NVCR)|Price-to-Revenue Ratio Alpha Tau Medical DRTS|Price-to-Revenue Coefficient Acrivon Therapeutics Inc (ACRV)|ALLR: Market Cap to Revenue